Compare, Analyse AJANTA PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
TEVA PHARMA
Dec-13
AJANTA PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,4222,973-   
Low Rs8982,582-   
Sales per share (Unadj.) Rs233.51,706.1-  
Earnings per share (Unadj.) Rs44.0106.6-  
Cash flow per share (Unadj.) Rs52.2244.5-  
Dividends per share (Unadj.) Rs9.0093.30-  
Dividend yield (eoy) %0.83.4 23.1%  
Book value per share (Unadj.) Rs255.11,895.1-  
Shares outstanding (eoy) m88.02848.00-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.01.6 305.1%   
Avg P/E ratio x26.426.1 101.2%  
P/CF ratio (eoy) x22.211.4 195.7%  
Price / Book Value ratio x4.51.5 310.2%  
Dividend payout %20.587.5 23.4%   
Avg Mkt Cap Rs m102,0812,355,388 4.3%   
No. of employees `0006.844.9 15.1%   
Total wages/salary Rs m4,3070-   
Avg. sales/employee Rs Th3,022.632,189.6 9.4%   
Avg. wages/employee Rs Th633.40-   
Avg. net profit/employee Rs Th569.12,010.9 28.3%   
INCOME DATA
Net Sales Rs m20,5541,446,763 1.4%  
Other income Rs m2110-   
Total revenues Rs m20,7651,446,763 1.4%   
Gross profit Rs m5,664396,197 1.4%  
Depreciation Rs m721116,943 0.6%   
Interest Rs m1228,417 0.0%   
Profit before tax Rs m5,143250,837 2.1%   
Minority Interest Rs m01,140 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-164,661 0.0%   
Tax Rs m1,273-3,062 -41.6%   
Profit after tax Rs m3,87090,378 4.3%  
Gross profit margin %27.627.4 100.6%  
Effective tax rate %24.8-1.2 -2,027.5%   
Net profit margin %18.86.2 301.4%  
BALANCE SHEET DATA
Current assets Rs m11,812977,138 1.2%   
Current liabilities Rs m3,776852,147 0.4%   
Net working cap to sales %39.18.6 452.5%  
Current ratio x3.11.1 272.8%  
Inventory Days Days7791 85.2%  
Debtors Days Days8296 85.1%  
Net fixed assets Rs m14,398472,545 3.0%   
Share capital Rs m1753,561 4.9%   
"Free" reserves Rs m22,2770-   
Net worth Rs m22,4521,607,079 1.4%   
Long term debt Rs m7739,762 0.0%   
Total assets Rs m26,9623,306,317 0.8%  
Interest coverage x444.39.8 4,521.6%   
Debt to equity ratio x00.5 0.1%  
Sales to assets ratio x0.80.4 174.2%   
Return on assets %14.43.6 400.7%  
Return on equity %17.25.6 306.5%  
Return on capital %23.04.9 465.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,5800-   
CASH FLOW
From Operations Rs m3,748230,539 1.6%  
From Investments Rs m-2,228-81,689 2.7%  
From Financial Activity Rs m-1,475-276,547 0.5%  
Net Cashflow Rs m45-127,697 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.22 Rs / USD

Compare AJANTA PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare AJANTA PHARMA With: VENUS REMEDIES  DR. REDDYS LAB  PIRAMAL ENTERPRISES  SUVEN LIFESCIENCES  ALKEM LABORATORIES  



Today's Market

Sensex Ends 246 Points Higher; Capital Goods and Power Stocks Witness Buying(Closing)

Extending gains to the sixth day, Indian share markets traded on a positive note most of the day and ended higher.

Related Views On News

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Oct 18, 2019 03:37 PM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS